Dan He1, Wan Dan1, Qing Du1, Bing-Bing Shen1, Lin Chen1, Liang-Zi Fang1, Jian-Jun Kuang1, Chun-Yu Tang2, Ping Cai1, Rong Yu1,3, Shui-Han Zhang1, Jian-Hua Huang1,3. 1. Hunan Academy of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410013, People's Republic of China. 2. Hunan Times Sunshine Pharmaceutical Co., Ltd., Changsha, Hunan, 425007, People's Republic of China. 3. Hunan Key Laboratory of TCM Prescription and Syndromes Translational Medicine Hunan, Changsha, Hunan, 410208, People's Republic of China.
Abstract
Purpose: This study aimed to reveal the multicomponent synergy mechanisms of SWP based on network pharmacology and metabolomics for exploring the relationships of active ingredients, biological targets, and crucial metabolic pathways. Materials: Network pharmacology, including TRRUST, GO, and KEGG, enrichment was used to discover the active ingredients and potential regulation mechanisms of SWP. LC-MS and multivariate data analysis method were further applied to analyze serum metabolomics profiling for discovering the potential metabolic mechanisms of SWP on AA induced by Cyclophosphamide (CTX) and 1-Acetyl-2-phenylhydrazine (APH). Results: A total of 27 important bioactive ingredients meeting the ADME (absorption, distribution, metabolism, and excretion) screening criteria from SWP were selected. Interaction networks were constructed and validated based on the 10 associated ingredients with the relevant targets. A total of 125 biomarkers were found by Metabolomics approach, which associated with the development of AA, mainly involved in amino acid metabolism and lipid metabolism. While SWP can reverse the above 12 metabolites changed by AA. Network analysis revealed the synergistic effects of SWP through the 43 crucial pathways, including Sphingolipid signaling pathway, Sphingolipid metabolism, Arginine and proline metabolism, VEGF signaling pathway, Estrogen signaling pathway. Conclusion: The study suggested that SWP is a useful alternative for the treatment of AA induced by CTX + APH. Its potential mechanisms are to improve hematopoietic microenvironment and promote bone marrow hematopoiesis therapies.
Purpose: This study aimed to reveal the multicomponent synergy mechanisms of SWP based on network pharmacology and metabolomics for exploring the relationships of active ingredients, biological targets, and crucial metabolic pathways. Materials: Network pharmacology, including TRRUST, GO, and KEGG, enrichment was used to discover the active ingredients and potential regulation mechanisms of SWP. LC-MS and multivariate data analysis method were further applied to analyze serum metabolomics profiling for discovering the potential metabolic mechanisms of SWP on AA induced by Cyclophosphamide (CTX) and 1-Acetyl-2-phenylhydrazine (APH). Results: A total of 27 important bioactive ingredients meeting the ADME (absorption, distribution, metabolism, and excretion) screening criteria from SWP were selected. Interaction networks were constructed and validated based on the 10 associated ingredients with the relevant targets. A total of 125 biomarkers were found by Metabolomics approach, which associated with the development of AA, mainly involved in amino acid metabolism and lipid metabolism. While SWP can reverse the above 12 metabolites changed by AA. Network analysis revealed the synergistic effects of SWP through the 43 crucial pathways, including Sphingolipid signaling pathway, Sphingolipid metabolism, Arginine and proline metabolism, VEGF signaling pathway, Estrogen signaling pathway. Conclusion: The study suggested that SWP is a useful alternative for the treatment of AA induced by CTX + APH. Its potential mechanisms are to improve hematopoietic microenvironment and promote bone marrow hematopoiesis therapies.
Authors: W D Jarvis; F A Fornari; K L Auer; A J Freemerman; E Szabo; M J Birrer; C R Johnson; S E Barbour; P Dent; S Grant Journal: Mol Pharmacol Date: 1997-12 Impact factor: 4.436
Authors: Adrienne Halupa; Monica L Bailey; Kai Huang; Norman N Iscove; David E Levy; Dwayne L Barber Journal: Blood Date: 2004-06-22 Impact factor: 22.113
Authors: Robin Ireland; Benjamin Schwarz; Glenn Nardone; Tara D Wehrly; Corey D Broeckling; Abhilash I Chiramel; Sonja M Best; Catharine M Bosio Journal: J Innate Immun Date: 2018-07-03 Impact factor: 7.349
Authors: Elena Ansó; Samuel E Weinberg; Lauren P Diebold; Benjamin J Thompson; Sébastien Malinge; Paul T Schumacker; Xin Liu; Yuannyu Zhang; Zhen Shao; Mya Steadman; Kelly M Marsh; Jian Xu; John D Crispino; Navdeep S Chandel Journal: Nat Cell Biol Date: 2017-05-15 Impact factor: 28.824